Inventor · disambiguated record
Georg Tiefenthaler
Also filed as: TIEFENTHALER GEORG
21 granted patents·20 pending applications·69 citations·filing 1999–2025
93Inventor score
Top patents by PatentIndex Score
41 records- 0189US10364292B2Monovalent blood brain barrier shuttle modulesHOFFMANN LA ROCHE·Filed 2016·Granted Jul 30, 2019·10 cites·10 claims
- 0289US8541204B2Polypeptide producing cellsHOFFMANN LA ROCHE·Filed 2012·Granted Sep 24, 2013·12 cites·1 claims
- 0387US8354516B2Polypeptide producing cellsHOFFMANN LA ROCHE·Filed 2007·Granted Jan 15, 2013·12 cites·12 claims
- 0484US7208526B2StyrylsulfonamidesHOFFMANN LA ROCHE·Filed 2006·Granted Apr 24, 2007·9 cites·55 claims
- 0582US11739142B2Bispecific anti-CCL2 antibodiesHOFFMANN LA ROCHE·Filed 2020·Granted Aug 29, 2023·1 cites·2 claims
- 0680US10106612B2Method for selection and production of tailor-made highly selective and multi-specific targeting entities containing at least two different binding entities and uses thereofHOFFMANN LA ROCHE·Filed 2014·Granted Oct 23, 2018·2 cites·8 claims
- 0779US2025051456A1Anti-hla-g antibodies and methods of use thereofHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 0878US9862779B2Method for the production and selection of molecules comprising at least two different entities and uses thereofHOFFMANN LA ROCHE·Filed 2015·Granted Jan 9, 2018·4 cites·13 claims
- 0977US12103967B2Bispecific anti-CCL2 antibodiesHOFFMANN LA ROCHE·Filed 2023·Granted Oct 1, 2024·0 cites·27 claims
- 1077US7625896B2Pyridylsulfonamide derivativesHOFFMANN LA ROCHE·Filed 2006·Granted Dec 1, 2009·3 cites·12 claims
- 1175US10407511B2Covalently linked helicar-anti-helicar antibody conjugates and uses thereofHOFFMANN LA ROCHE·Filed 2016·Granted Sep 10, 2019·2 cites·9 claims
- 1273US2023220110A1Method for selection and production of tailor-made highly selective and multi-specific targeting entities containing at least two different binding entities and uses thereofHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 1372US7091345B2Amino-substituted dihydropyrimido[4,5-D]pyrimidinone derivativesHOFFMANN LA ROCHE·Filed 2003·Granted Aug 15, 2006·9 cites·39 claims
- 1472US2024083993A1Bispecific anti-ccl2 antibodiesHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1571US2025051455A1Multispecific antibodies and use thereofHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 1666US2025163173A1Monovalent blood brain barrier shuttle modulesHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 1765US11407836B2Method for selection and production of tailor-made highly selective and multi-specific targeting entities containing at least two different binding entities and uses thereofHOFFMANN LA ROCHE·Filed 2018·Granted Aug 9, 2022·0 cites·4 claims
- 1864US12466889B2Anti-HLA-G antibodies and use thereofHOFFMANN LA ROCHE·Filed 2022·Granted Nov 11, 2025·0 cites·91 claims
- 1964US12157770B2Anti-HLA-G antibodies and methods of use thereofHOFFMANN LA ROCHE·Filed 2020·Granted Dec 3, 2024·0 cites·11 claims
- 2063US2020299385A1Antibodies binding to human and cynomolgus cd3 epsilonHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 2163US2020325224A1Antibodies binding to human and cynomolgus cd3 epsilonHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 2262US12024548B2Rapid method for cloning and expression of cognate antibody variable gene segmentsHOFFMANN LA ROCHE·Filed 2019·Granted Jul 2, 2024·0 cites·6 claims
- 2361US10562973B2Blood-brain barrier shuttles containing antibodies recognizing alpha-synucleinPROTHENA BIOSCIENCE LTD·Filed 2015·Granted Feb 18, 2020·1 cites·40 claims
- 2459US11981737B2Anti-HLA-G antibodies and use thereofHOFFMANN LA ROCHE·Filed 2019·Granted May 14, 2024·0 cites·9 claims
- 2559US2014302559A1Rapid method for cloning and expression of cognate antibody variable region gene segmentsHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 2659US2022213199A1Anti-HLA-G antibodies and use thereofHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 2756US2021147554A1Multispecific antibodies and use thereofHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 2856US2020071413A1Monovalent blood brain barrier shuttle modulesHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 2955US2017210785A1Rapid method for cloning and expression of cognate antibody variable region gene segmentsHOFFMANN LA ROCHE·Filed 2017·Application pending·0 cites
- 3055US2017233475A1Antibodies binding to human and cynomolgus cd3 epsilonHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 3154US7208506B2Heteroarylethenyl derivatives, their manufacture and use as pharmaceutical agentsHOFFMANN LA ROCHE·Filed 2006·Granted Apr 24, 2007·0 cites·48 claims
- 3252US2020299397A1Blood-Brain Barrier Shuttles Containing Antibodies Recognizing Alpha-SynucleinPROTHENA BIOSCIENCE LTD·Filed 2020·Application pending·0 cites
- 3349US2015232560A1Method for the selection and production of tailor-made, selective and multi-specific therapeutic molecules comprising at least two different targeting entities and uses thereofHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 3448US12497434B2IL-37 fusion proteins and uses thereofHOFFMANN LA ROCHE·Filed 2020·Granted Dec 16, 2025·0 cites·16 claims
- 3543US11162127B2Enzymatic one-pot reaction for double polypeptide conjugation in a single stepHOFFMANN LA ROCHE·Filed 2017·Granted Nov 2, 2021·0 cites·12 claims
- 3643US2014051834A1Incretin Receptor Ligand Polypeptide Fc-Region Fusion Polypeptides And Conjugates With Altered Fc-Effector FunctionHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 3741US2004132739A1Combination of a gelatinase inhibitor and an anti-tumor agent, and uses thereofFiled 2002·Application pending·0 cites
- 3841US2016333386A1Use of peptidylglycine alpha-amidating monooxigenase (pam) for c-terminal amidationHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 3940US6475786B1Amphotropic retrovirus packaging cell line, process for its production and use thereofROCHE DIAGNOSTICS GMBH·Filed 1999·Granted Nov 5, 2002·4 cites·4 claims
- 4039US2013266565A1Anti-mhc antibody anti viral cytokine fusion proteinHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 4136US2012020988A1Antibodies specifically binding to human TSLPR and methods of useAUER JOHANNES·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Georg Tiefenthaler files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →